Clinical cerenkov luminescence imaging of 18F-FDG

Journal of Nuclear Medicine

Volumn 55, Issue 1, 2014, Pages 95-98

  Thorek, Daniel L J ^a   Riedl, Christopher C ^a   Grimm, Jan ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cerenkov luminescence imaging; Clinical; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BREAST CANCER; CAMERA; CERENKOV LUMINESCENCE IMAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEASIBILITY STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; LUMINESCENCE; LUNG CANCER; LYMPHOMA; MALE; MICROFLUIDIC ANALYSIS; NON INVASIVE PROCEDURE; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOCHEMISTRY; REFRACTION INDEX; WHITE LIGHT; 18F-FDG; CLINICAL; COHORT ANALYSIS; FLUORESCENCE IMAGING; METHODOLOGY; MIDDLE AGED; MULTIMODAL IMAGING; PET/CT; PHOTON; TIME;

18F-FDG; CERENKOV LUMINESCENCE IMAGING; CLINICAL; PET/CT;

COHORT STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUMINESCENCE; MALE; MIDDLE AGED; MULTIMODAL IMAGING; OPTICAL IMAGING; PHOTONS; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84894767436     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.127266     Document Type: Article

References (17)

1. Ntziachristos V, Ripoll J, Wang LV, Weissleder R. Looking and listening to light. Nat Biotechnol. 2005;23: 313-320.
2. Willmann JK, van Bruggen N, Dinkelborg LM, Gahbhir SS. Molecular imaging in drug development. Nat Rev Drug Discov. 2008;7: 591-607.
3. Byrne WL, Delille A, Kuo C, et al. Use of optical imaging to progress novel therapeutics to the clinic. J Control Release. May 13, 2013 [Epub ahead of print].
4. Cho JS, Taschereau R, Olma S, et al. Cerenkov radiation imaging as a method for quantitative measurements of beta particles in a microfluidic chip. Phys Med Biol. 2009;54: 6757-6771.
5. Spinelli AE, D'Ambrosio D, Calderan L, Marengo M, Sbarbati A, Boschi F. Cerenkov radiation allows in vivo optical imaging of positron emitting radiotracers. Phys Med Biol. 2010;55: 483-495.
6. Robertson R, Germanos MS, Li C, Mitchell GS, Cherry SR, Silva MD. Optical imaging of Cerenkov light generation from positron-emitting radiotracers. Phys Med Biol. 2009;54: N355-N365.
7. Cherenkov PA. Visible emission of clean liquids by action of gamma-radiation. Dokl Akad Nauk SSSR. 1934;2: 451-452.
8. Thorek DLJ, Robertson R, Bacchus WA, et al. Cerenkov imaging: a new modality for molecular imaging. Am J Nucl Med Mol Imaging. 2012;2: 163-173.
9. Xu Y, Chang E, Liu H, Jiang H, Gambhir SS, Chen Z. Proof-of-concept study of monitoring cancer drug therapy with Cerenkov luminescence imaging. J Nucl Med. 2012;53: 312-317.
10. Beattie BJ, Thorek DLJ, Schmidtlein CR, Pentlow PS, Humm JL, Hielscher AH. Quantitative modeling of Cerenkov light production efficiency from medical radionuclides. PLoS ONE. 2012;7: e31402.
11. Chin PT, Welling MM, Meskers SC, Valdes Olmos RA, Tanke H, van Leeuwen FW. Optical imaging as an expansion of nuclear medicine. Eur J Nucl Med Mol Imaging. 2013;40: 1283-1291.
12. Spinelli AE, Ferdeghini M, Cavedon C, et al. First human Cernekography. J Biomed Opt. 2013;18: 20502.
13. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9: 671-675.
14. 18F-FDG. J Nucl Med. 2012;53: 1438-1445.
15. Nebesio TD, Siddiqui AR, Pescovitz OH, Eugster EA. Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children. J Pediatr. 2002;141: 99-103.
16. Spinelli AE, Boschi F. Optimizing in vivo small animal Cerenkov luminescence imaging. J Biomed Opt. 2012;17: 040506.
17. Ruggiero A, Holland JP, Lewis JS, Grimm J. Cerenkov luminescence imaging of medical isotopes. J Nucl Med. 2010;51: 1123-1130.